KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Bionano Genomics (BNGO) Other Gross PP&E Adjustments (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Other Gross PP&E Adjustments for 9 consecutive years, with $37.5 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments fell 10.98% to $37.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.5 million through Dec 2025, down 10.98% year-over-year, with the annual reading at $37.5 million for FY2025, 10.98% down from the prior year.
  • Other Gross PP&E Adjustments hit $37.5 million in Q4 2025 for Bionano Genomics, up from -$3.5 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $42.1 million in Q4 2024 to a low of -$7.0 million in Q1 2022.
  • Historically, Other Gross PP&E Adjustments has averaged $6.2 million across 5 years, with a median of -$3.5 million in 2024.
  • Biggest five-year swings in Other Gross PP&E Adjustments: surged 78.87% in 2024 and later crashed 365.65% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at $14.6 million in 2021, then surged by 76.26% to $25.8 million in 2022, then surged by 43.35% to $36.9 million in 2023, then rose by 14.12% to $42.1 million in 2024, then fell by 10.98% to $37.5 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for BNGO at $37.5 million in Q4 2025, -$3.5 million in Q3 2025, and -$3.8 million in Q2 2025.